source
- Biopharma exec pay reveals quirky perks like private jets and wildfire relief grantsA recent review of thousands of biopharma C‑suite compensation packages found that most line items blend into the massive totals, but a few stand out for their unusual nature. Among the highlighte…
- J&J reports positive Phase 2/3 results for Imaavy in rare autoimmune anemia, paving way for label expansionJohnson & Johnson announced that its drug Imaavy, already approved for myasthenia gravis, produced durable hemoglobin improvements in a Phase 2/3 trial for warm autoimmune hemolytic anemia, a rare…